Regulatory Focus Target Life Sciences firms needing compliant, high-risk localization. Idem’s ISO certifications and expertise in regulatory materials position it for expansion with medical device, pharmaceutical, and biotech companies seeking global market entry and ongoing compliance.

Quality Credentials Leverage Idem’s woman-owned status and robust quality certifications (ISO 9001:2015, ISO 13485:2016, ISO 17100:2015) to differentiate in bids requiring stringent quality and regulatory alignment for high-stakes translations.

Global Platform Highlight the ability to scale multilingual content through a global platform to support large volumes of IFUs, clinical and regulatory documents—appealing to midsize to enterprise Life Sciences companies with international footprint.

Tech Synergy Position as a partner that complements existing MT/DT/CAT stacks by offering proven workflow with Adobe GoLive and Apache-based tooling, enabling seamless integration into clients’ localization pipelines.

Growth Path Bridge opportunities with mid-market peers and similar service providers in the $100M–$500M revenue band looking to augment specialized localization capabilities, while showcasing Idem’s 40+ years of industry experience as a risk-mitigated option.